Suanfarma Suanfarma

X

CAS 152460-07-06 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 152460-07-06
Also known as: 152460-07-6, Guanidine,(2-methyl-5-nitrophenyl), 1-(2-methyl-5-nitrophenyl)guanidine, 2-(2-methyl-5-nitrophenyl)guanidine, Guanidine,n-(2-methyl-5-nitrophenyl)-, Schembl1583292
Molecular Formula
C8H10N4O2
Molecular Weight
194.19  g/mol
InChI Key
LAZBONZCMJREIQ-UHFFFAOYSA-N

1 2D Structure

CAS 152460-07-06

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(2-methyl-5-nitrophenyl)guanidine
2.1.2 InChI
InChI=1S/C8H10N4O2/c1-5-2-3-6(12(13)14)4-7(5)11-8(9)10/h2-4H,1H3,(H4,9,10,11)
2.1.3 InChI Key
LAZBONZCMJREIQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C=C(C=C1)[N+](=O)[O-])N=C(N)N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 152460-07-6

2. Guanidine,(2-methyl-5-nitrophenyl)

3. 1-(2-methyl-5-nitrophenyl)guanidine

4. 2-(2-methyl-5-nitrophenyl)guanidine

5. Guanidine,n-(2-methyl-5-nitrophenyl)-

6. Schembl1583292

7. (2-methyl-5-nitrophenyl)guanidine

8. Zinc2513613

9. Akos006280007

10. Mb02715

11. N-(2-methyl-5-nitrophenyl)-guanidine

12. Db-063944

13. Ft-0701528

14. J3.562.571b

15. 460m076

16. J-522958

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 194.19 g/mol
Molecular Formula C8H10N4O2
XLogP31
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass194.08037557 g/mol
Monoisotopic Mass194.08037557 g/mol
Topological Polar Surface Area110 Ų
Heavy Atom Count14
Formal Charge0
Complexity244
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
152460-07-06
Imatinib Mesylate
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

India Med Expo

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY